​COVID-19 and Cancer: Addressing Patients' Concerns With Mark A. Lewis, MD

Patients with cancer often have concerns related to the COVID-19 pandemic, from which they are potentially at increased danger as a result of their cancer and/or due to immunosuppressive treatments. Mark A. Lewis, MD, Director of Gastrointestinal Oncology at Intermountain Healthcare, Murray, Utah, recently published a perspective piece in The New England Journal of Medicine contemplating the challenges of balancing the necessity of cancer care against the risks of COVID-19. A couple of week...

Continue reading

Oncology Practice and COVID-19: Addressing the Challenges With Mark A. Lewis, MD

The COVID-19 pandemic has created multiple challenges to cancer care, ranging from the risk of exposure to novel coronavirus involved in having patients come to the hospital or clinic for treatment to the risks that immunosuppressive cancer treatments––and cancer itself––may pose in making patients more susceptible to COVID-19. How should these risks be balanced against the necessity of life-preserving cancer therapies? Mark A. Lewis, MD, Director of Gastrointestinal Oncology at Intermountain He...

Continue reading

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2022 Oncology Data Advisor. All rights reserved.